Invalidated studies
Non-compliant labeling can void trial results.
Every clinical trial label is a specific combination of protocol, strength, storage, and caution statements, varying by study, package, country, and language. ComplianceAuthor AI® assembles them from approved phrases and enforced country-specific regulations, taking the label lifecycle from over four weeks to as little as four days.
Drug & strength
Investigational Product 50 mg
Dosage
Take one tablet by mouth once daily.
Caution
For clinical trial use only. Keep out of reach of children.
Why it matters
Manual, paper-based labeling creates GMP deviations and verification gaps. The consequences scale fast, and they're rarely just operational.
Non-compliant labeling can void trial results.
A labeling error in the field can force a costly product recall.
Rework pushes timelines and burns runway.
A missed deadline is an opening for rivals.
Rules in action
Change the study parameters and watch the label rebuild itself. Approved phrases, translations, and digitized country-specific rules are stored once, so the right label assembles automatically for each country, package, and study type, first authored in English, then generated into every required language. Adjust the controls to see it.
Study parameters
Country & language
Package type
Study design
Rules fired
PROT-2741 · Sponsor XYZ
Investigational Product 50 mg
Take one tablet by mouth once daily.
Storage & handling
Store at 20 to 25°C (68 to 77°F).
Caution
Keep out of reach of children.
Blinded medication: do not disclose contents to the subject.
For clinical trial use only. Not for sale. Keep out of reach of children.
Authored once in English - generated in every required language.
The cost of translation
Re-translating the same approved phrases (study after study, label after label) is one of the largest hidden costs in clinical supply. It's slow, it's expensive, and it reintroduces risk every time.
Glemser stores approved phrases and their validated translations. Once a phrase is approved in a language, it's never retranslated. Teams move extremely fast and save hundreds of thousands of dollars.
“For clinical trial use only.”
Approved · ENTranslate once · reuse forever · never re-validate
From weeks to days
Authoring, review, translation, and output generation in one validated flow, connected to downstream operations, reduces end-to-end output generation timelines by up to 80%.
Approved phrases, translations, and business rules, digitized into components.
Rule-based assembly generates the label for each study, country, and combination.
Review and approval workflows with full audit trail.
Generate every required language from stored translations.
Publish print-ready output directly, then hand off to printing and execution without disruption.
Customer story
From a manual, paper-based process with GMP deviation risk to validated, automated labeling with audit-ready control they can demonstrate to regulators on demand.
Top 10 global pharma
A long-running partnership that replaced fragile clinical labeling operations with governed, reusable content.
4 wks → 4 days
Label generation lifecycle
Since 2015
In continuous production
Audit-ready
Demonstrable to regulators on demand
A focused walkthrough on your study types, packages, and markets, and the rules that drive them.